| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-05 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |